Skip to content
Live

Photo: KJ Brix on Pexels

AI Startups

Multiply Labs raises $75M Series B for pharmaceutical robotics

NantWorks leads funding for automation startup targeting drug manufacturing.

Summarized from Techmeme, . 25-second read.

This story is from October 11, 2026. For the latest, see today's news.

Listen to this story
0:00 / 0:00

Multiply Labs, a startup building robotic systems to automate pharmaceutical manufacturing, closed a $75 million Series B round led by NantWorks, the investment firm backed by billionaire Patrick Soon-Shiong.

The funding will support the company's efforts to scale its automation technology for drugmakers. Pharmaceutical manufacturing has been a target for robotics and AI-driven automation as companies seek to improve efficiency and reduce manual labor in production.

Multiply Labs joins a growing wave of startups applying robotics and automation to regulated industries, where precision and consistency are critical.

Read the full story at Techmeme

This is an AI-written summary. The original reporting belongs to Techmeme. How we write these · Spot a mistake?

Share

Get the AI brief every morning.

The five AI stories that matter each morning: startups, money, jobs, tech and what's coming next. Free, and one click to unsubscribe. See our Privacy Policy.